| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.008 | 0.9 |